Please login to the form below

Not currently logged in
Email:
Password:

Teva/Pfizer settle Neurontin suit

Teva Pharmaceutical has announced it has settled a patent dispute with Pfizer concerning generic versions of Pfizer's Neurontin (gabapentin) – a drug marketed for pain management and the treatment of epilepsy

Teva Pharmaceutical has announced it has settled a patent dispute with Pfizer concerning generic versions of Pfizer's Neurontin (gabapentin) – a drug marketed for pain management and the treatment of epilepsy.

The Israel-based generic manufacturer said litigation related to capsules and tablets sold by the company and its subsidiary Ivax Pharmaceuticals has been 'dismissed' by United States District Court for the District of New Jersey in accordance with a settlement reached between the two parties.

Teva did not reveal financial details of the settlement, but reports have suggested it is less than $100m.

Pfizer had filed litigation claiming that Teva's generic version infringed a patent that expires in 2017, with the US-based drugmaker seeking compensation for profit lost due to competition.

A generic gabapentin was launched by Ivax in 2004. Teva later purchased Ivax in 2006.

1st June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics